AstraZeneca Pharma India, an integrated biopharmaceutical company, witnessed a sharp rise in share price on Thursday after the company swung to a profit for the quarter ended March 2015.  During the quarter, the company reported a profit of Rs 381.20 million compared with a loss of Rs 25.60 million  in the same quarter previous year.

Revenues for the quarter   jumped 47.66% to Rs 1,685.50 million, compared with Rs 1,142 million for the prior year period.

Shares of Astrazeneca Pharma India are trading at Rs 970.00, up Rs 111.95, or 13.05% at the Bombay Stock Exchange (BSE) on Thursday at 1:27 p.m.

Total volume of shares traded on the bourses today was lower by 50.66% to 275,070 compared with 22-day average volume of 557,484.